«Clinical and laboratory predictors of therapeutic response to Tocilizumab in rheumatoid arthritis». One Health & Risk Management 6, no. 3 (september 6, 2025): 44–53. åpnet juli 22, 2026. https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/827.